$4.63
-0.13-2.73%
At Close: -
$4.63
00.00%
After Hours: Jul 19, 4:01 PM EDT
15 minutes delayed
Comments
Loading...
Achieve Life Sciences
ACHVNASDAQ
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Achieve Life Sciences (NASDAQ:ACHV) Stock, Analyst Ratings, Price Targets, Forecasts
Achieve Life Sciences Inc has a consensus price target of $15 based on the ratings of 5 analysts. The high is $25 issued by Alliance Global Partners on October 4, 2021. The low is $8 issued by Maxim Group on November 16, 2022. The 3 most-recent analyst ratings were released by Oppenheimer, JonesTrading, and Oppenheimer on May 13, 2024, April 17, 2024, and April 1, 2024, respectively. With an average price target of $16.33 between Oppenheimer, JonesTrading, and Oppenheimer, there's an implied 252.77% upside for Achieve Life Sciences Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Oppenheimer
JonesTrading
Lake Street
Maxim Group
Alliance Global Partners
1calculated from analyst ratings
Analyst Ratings for Achieve Life Sciences
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/13/2024 | Buy Now | 137.58% | Oppenheimer | Francois Brisebois | $18 → $11 | Maintains | Outperform | Get Alert |
| 04/17/2024 | Buy Now | 331.97% | JonesTrading | Justin Walsh | → $20 | Initiates | → Buy | Get Alert |
| 04/01/2024 | Buy Now | 288.77% | Oppenheimer | Francois Brisebois | $18 → $18 | Reiterates | Outperform → Outperform | Get Alert |
| 03/05/2024 | Buy Now | 137.58% | Lake Street | Thomas Flaten | $19 → $11 | Maintains | Buy | Get Alert |
| 12/12/2023 | Buy Now | 288.77% | Oppenheimer | Francois Brisebois | $21 → $18 | Maintains | Outperform | Get Alert |
| 05/31/2023 | Buy Now | 310.37% | Lake Street | Thomas Flaten | $22 → $19 | Maintains | Buy | Get Alert |
| 05/10/2023 | Buy Now | 375.16% | Lake Street | Thomas Flaten | → $22 | Maintains | Buy | Get Alert |
| 03/17/2023 | Buy Now | 267.17% | Oppenheimer | Francois Brisebois | → $17 | Reiterates | → Outperform | Get Alert |
| 11/16/2022 | Buy Now | 72.79% | Maxim Group | Jason McCarthy | $21 → $8 | Maintains | Buy | Get Alert |
| 10/04/2021 | Buy Now | 439.96% | Alliance Global Partners | James Molloy | — | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Achieve Life Sciences (ACHV) stock?
The latest price target for Achieve Life Sciences (NASDAQ:ACHV) was reported by Oppenheimer on May 13, 2024. The analyst firm set a price target for $11.00 expecting ACHV to rise to within 12 months (a possible 137.58% upside). 5 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Achieve Life Sciences (ACHV)?
The latest analyst rating for Achieve Life Sciences (NASDAQ:ACHV) was provided by Oppenheimer, and Achieve Life Sciences maintained their outperform rating.
When was the last upgrade for Achieve Life Sciences (ACHV)?
There is no last upgrade for Achieve Life Sciences
When was the last downgrade for Achieve Life Sciences (ACHV)?
There is no last downgrade for Achieve Life Sciences.
When is the next analyst rating going to be posted or updated for Achieve Life Sciences (ACHV)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Achieve Life Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Achieve Life Sciences was filed on May 13, 2024 so you should expect the next rating to be made available sometime around May 13, 2025.
Is the Analyst Rating Achieve Life Sciences (ACHV) correct?
While ratings are subjective and will change, the latest Achieve Life Sciences (ACHV) rating was a maintained with a price target of $18.00 to $11.00. The current price Achieve Life Sciences (ACHV) is trading at is $4.63, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.